Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
REGENECYTE (StemCyte Inc.)
- Development stage
- Unknown
- Lead developer
- StemCyte
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
REGENECYTE is an allogeneic human umbilical cord blood (hUCB) cell therapy developed by StemCyte Taiwan Co., Ltd. for the treatment of cerebral palsy. The therapy consists of a diverse population of cells derived from donor umbilical cord blood, including hematopoietic stem cells and other progenitor cell populations. Administered via intravenous infusion, the therapy is intended to provide neuroprotective effects, improve brain connectivity, and enhance motor function in children with cerebral palsy. The biological mechanism is thought to involve the release of anti-inflammatory cytokines and growth factors that promote neural repair and modulate the immune response within the central nervous system.
- Brand names
- REGENECYTE
- Other names
- allogeneic human umbilical cord bloodallogeneic hUCBhuman umbilical cord blood
Beyond the preview
Go deeper on REGENECYTE (StemCyte Inc.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on REGENECYTE (StemCyte Inc.).